Developments in biosimilars, increasing prevalence rate of Inflammatory Bowel disease, and changing lifestyle have resulted in boosting the Ulcerative Colitis Drug market.  The global Ulcerative Colitis Drug market is forecast to reach USD 10.69 Billion by 2028, according to a new report by Reports and Data. Inflammatory bowel disease (UC) can be defined as an...